Articles

Goldman Sachs stock up after Q4 profit rises by 58% and beats analyst estimate

Goldman Sachs Group Inc.'s stock rose in premarket trading on Tuesday after the investment bank said its fourth-quarter profit rose by 5.8% and beat analysts' reduced expectations as it capped off a difficult year of slack deal-making and restructuring.

World’s top funds pile into real estate, cash and commodities in bid to shield themselves against interest rate cuts

Investment funds with $256 billion of assets under management piled out of bonds, banks and insurance companies

Burger King to buy franchisee Carrols so it can ‘rapidly remodel’ restaurants

Carrols to be acquired for a 13% premium, in a deal valued at $1 billion

Like their Fed peers, ECB officials challenge the market’s rate-cut optimism

European Central Bank officials have been mostly matching their U.S. peers in pushing back against investors' optimism that interest rates will be cut swiftly in coming months.

Another Wall Street bank has boosted its S&P 500 target. Here’s why.

A call of the day from a Wall Street bank that has leapfrogged its year-end stock outlook.

How to help American families afford child care? Give parents money directly

Boost the child tax credit and let parents decide whether to care for their children at home or in daycare.

Oil prices rise as Middle East tensions continue

Oil futures rise modestly Monday as traders monitor the Middle East.

Elon Musk says wants more control over Tesla

The world's richest person said he doesn't have enough control over the company where he's chief executive and the leading shareholder.

Ten-year Treasury tops 4% as central banks try to cool traders’ rate-cut optimism

Bond yields rose early Tuesday after more central bank officials indicated markets were getting too optimistic about the pace of interest rate cuts in 2024.

Sell AstraZeneca, says UBS, which upgrades European rivals including GSK

UBS analysts shook up their ratings of European drugmakers, including making a double-downgrade of AstraZeneca and a double-upgrade of U.K. rival GSK.

Hugo Boss shares tumble on earnings miss forecast

Shares of Hugo Boss fell as much as 11% on Tuesday after the iconic German clothing company said its fourth-quarter earnings would fall short of analyst expectations.

China reportedly imposes fresh limits on investors’ abilities to sell shares

Chinese authorities are seeking to reverse a drop in the value of the country's benchmark CSI 300 stock index
1 1,556 1,557 1,558 1,559 1,560 2,300